Skip to content

Clinical study for rapid detection of novel coronavirus pneumonia (COVID-19) nucleic acid

Clinical study for rapid detection of novel coronavirus pneumonia (COVID-19) nucleic acid

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033104
Enrollment
Unknown
Registered
2020-05-21
Start date
2020-03-07
Completion date
Unknown
Last updated
2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Gold Standard:1. Real-time RT-PCR of respiratory tract or blood samples was positive for the SARS-Cov-2
acid&#32
test&#32
for&#32
in&#32
or&#32
swab&#32
samples

Sponsors

The Third People's Hospital of Hubei Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 95 Years

Inclusion criteria

Inclusion criteria: In reference to the novel coronavirus pneumonia diagnosis and treatment scheme, the following cases were included: (1) suspected covid-19 cases, cases released from isolation and discharged from hospital, and confirmed covid-19 cases with negative previous tests; (2) the age distribution of the enrolled population is representative.

Exclusion criteria

Exclusion criteria: Sample collection time or information is not clear;Insufficient test operation as a result of errors in sample size of samples; Found before operation test specimens preserved by the polluters; Statistics found that before any lack of original record the required information to a clinical study of cases, any doubt exists not sure the operation of the samples.

Design outcomes

Primary

MeasureTime frame
COVID-19 nucleic acid;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactDaming Wang
wangdm@sibet.ac.cn+86 13806010202

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026